Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Benda Pharmaceutical, commonly known as Yidu Benda, is a specialized pharmaceutical company headquartered in Yidu, Hubei Province, China. The firm is a global leader in the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and chemical intermediates, with a core focus on Vitamin B1 and its derivatives. Its flagship product, Benfotiamine, is widely utilized in the treatment of diabetic complications and metabolic disorders. Benda Pharmaceutical operates advanced manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards, ensuring high-quality supply for the global pharmaceutical and nutraceutical sectors. By combining chemical synthesis expertise with robust production capabilities, the company has established itself as a critical link in the international medicinal chemical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yidu Benda.